129
Views
3
CrossRef citations to date
0
Altmetric
Clinical Features

Hypoactive Sexual Desire Disorder in Premenopausal Women: Case Studies

, MD, , MD & , MD
Pages 94-103 | Published online: 13 Mar 2015

References

  • . Kaplan HS. Disorders of Sexual Desire and Other New Concepts and Techniques in Sex Therapy. New York, NY: Brunner/Hazel Publications; 1979
  • . Masters WH, Johnson VE. Human Sexual Response. Boston, MA: Little, Brown; 1966
  • . Basson R. Women's sexual dysfunction: revised and expanded definitions. CMAJ. 2005;172(10):1327–1333
  • . American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition–Text Revision. Washington, DC: American Psychiatric Publishing Inc; 2000
  • . Basson R. Women's sexual function and dysfunction: current uncertainties, future directions. Int J Impot Res. 2008;20(5):466–478
  • . Basson R, Leiblum S, Brotto L,. Revised definitions of women's sexual dysfunction. J Sex Med. 2004;1(1):40–48
  • . Segraves R, Balon R, Clayton A. Proposal for changes in diagnostic criteria for sexual dysfunctions. J Sex Med. 2007;4(3):567–580
  • . Rosen RC, Shifren JL, Monz BU, Odom DM, Russo PA, Johannes CB. Correlates of sexually related personal distress in women with low sexual desire. J Sex Med. 2009;6(6):1549–1560
  • . Shifren JL, Monz BU, Russo PA, Segreti A, Johannes CB. Sexual problems and distress in United States women: prevalence and correlates. Obstet Gynecol. 2008;112(5):970–978
  • . Ford ES, Li C, Zhao G. Prevalence and correlates of metabolic syndrome based on a harmonious definition among adults in the US. J Diabetes. 2010;2(3):180–193
  • . Esposito K, Ciotola M, Marfella R, Di Tommaso D, Cobellis L, Giugliano D. Sexual dysfunction in women with the metabolic syndrome. Diabetes Care. 2005;28(3):756
  • . Ponholzer A, Temml C, Rauchenwald M, Marszalek M, Madersbacher S. Is the metabolic syndrome a risk factor for female sexual dysfunction in sexually active women? Int J Impot Res. 2008;20(1):100–104
  • . Giraldi A, Kristensen E. Sexual dysfunction in women with diabetes mellitus. J Sex Res. 2010;47(2):199–211
  • . Esposito K, Ciotola M, Maiorino MI,. Hyperlipidemia and sexual function in premenopausal women. J Sex Med. 2009;6(6):1696–1703
  • . Esposito K, Ciotola M, Giugliano F,. Association of body weight with sexual function in women. Int J Impot Res. 2007;19(4): 353–357
  • . Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486–2497
  • . Giugliano F, Maiorino MI, Di Palo C,. Adherence to Mediterranean diet and sexual function in women with type 2 diabetes. J Sex Med. 2010;7(5):1883–1890
  • . Jones TH, Arver S, Behre HM,. Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study). Diabetes Care. 2011;34(4):828–837
  • . Pujols Y, Seal BN, Meston CM. The association between sexual satisfaction and body image in women. J Sex Med. 2010;7(2 pt 2):905–916
  • . Panjari M, Bell RJ, Davis SR. Sexual function after breast cancer. J Sex Med. 2011;8(1):294–302
  • . Sadovsky R, Basson R, Krychman M,. Cancer and sexual problems. J Sex Med. 2010;7(1 pt 2):349–373
  • . Hawkins Y, Ussher J, Gilbert E, Perz J, Sandoval M, Sundquist K. Changes in sexuality and intimacy after the diagnosis and treatment of cancer: the experience of partners in a sexual relationship with a person with cancer. Cancer Nurs. 2009;32(4):271–280
  • . Ofman U. “…And how are things sexually?” helping patients adjust to sexual changes before, during, and after cancer treatment. Support Cancer Ther. 2004;1(4):243–247
  • . Kagan R. Therapeutic options for the treatment of vaginal atrophy. http://www.obgmanagement.com/article_pages.asp?AID=9284. Published 2010. Accessed September 13, 2011
  • . Premarin (conjugated estrogens) vaginal cream [package insert]. Philadelphia, PA: Wyeth Pharmaceuticals; April 2010
  • . Estrace cream (estradiol vaginal cream, USP 0.01%) [package insert]. Rockaway, NJ: Warner Chilcott (US), LLC; September 2009
  • . Vagifem (estradiol vaginal tablets) [package insert]. Princeton, NJ: Novo Nordisk Inc; November 25, 2009
  • . Estring (estradiol vaginal ring) [package insert]. New York, NY: Pfizer Inc.; August 2008
  • . Femring (estradiol acetate vaginal ring) [package insert]. Rockaway, NJ: Warner Chilcott (US) LLC; April 2010
  • . Sadovsky R, Nusbaum M. Sexual health inquiry and support is a primary care priority. J Sex Med. 2006;3(1):3–11
  • . New Jersey Academy of Family Physicians. Family physician's guide to diagnosing hypoactive sexual desire disorder: first, communication. An evidence-based CME consensus recommendation from an expert panel. CME Report. 2010;6(2):1–24
  • . Clayton AH, Goldfischer ER, Goldstein I, Derogatis L, Lewis–D'Agostino DJ, Pyke R. Validation of the decreased sexual desire screener (DSDS): a brief diagnostic instrument for generalized acquired female hypoactive sexual desire disorder (HSDD). J Sex Med. 2009; 6(3):730–738
  • . Annon JS. Behavioral Treatment of Sexual Problems: Brief Therapy. New York, NY: Harper and Row; 1976
  • . The role of testosterone therapy in postmenopausal women: position statement of The North American Menopause Society. Menopause. 2005;12(5):496–511; quiz 649
  • . Wierman ME, Basson R, Davis SR,. Androgen therapy in women: an Endocrine Society Clinical Practice guideline. J Clin Endocrinol Metab. 2006;91(10):3697–3710
  • . Braunstein GD. Safety of testosterone treatment in postmenopausal women. Fertil Steril. 2007;88(1):1–17
  • . Braunstein GD. Management of female sexual dysfunction in post-menopausal women by testosterone administration: safety issues and controversies. J Sex Med. 2007;4(4 pt 1):859–866
  • . Fogle RH, Stanczyk FZ, Zhang X, Paulson RJ. Ovarian androgen production in postmenopausal women. J Clin Endocrinol Metab. 2007; 92(8):3040–3043
  • . Judd HL, Lucas WE, Yen SS. Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer. Am J Obstet Gynecol. 1974;118(6):793–798
  • . Basson R. Female sexual dysfunction in hypopituitarism. Lancet. 2007;370;9589:737; author reply 737–738
  • . Davis SR, Davison SL, Donath S, Bell RJ. Circulating androgen levels and self-reported sexual function in women. JAMA. 2005;294(1): 91–96
  • . Guay AT, Jacobson J. Decreased free testosterone and dehydroepiandrosterone-sulfate (DHEA-S) levels in women with decreased libido. J Sex Marital Ther. 2002;28( suppl 1):129–142
  • . Hornsby PJ. Biosynthesis of DHEAS by the human adrenal cortex and its age-related decline. Ann NY Acad Sci. 1995;774:29–46
  • . Labrie F, Belanger A, Cusan L, Gomez JL, Candas B. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab. 1997;82(8):2396–2402
  • . Orentreich N, Brind JL, Rizer RL, Vogelman JH. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab. 1984;59(3):551–555
  • . Braunstein GD, Sundwall DA, Katz M,. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Arch Intern Med. 2005;165(14):1582–1589
  • . Buster JE, Kingsberg SA, Aguirre O,. Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial. Obstet Gynecol. 2005;105(5 pt 1):944–952
  • . Davis SR, Moreau M, Kroll R,. Testosterone for low libido in post-menopausal women not taking estrogen. N Engl J Med. 2008;359(19): 2005–2017
  • . Davis SR, van der Mooren MJ, van Lunsen RH,. efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Menopause. 2006;13(3):387–396
  • . Shifren JL, Braunstein GD, Simon JA,. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med. 2000;343(10):682–688
  • . Shifren JL, Davis SR, Moreau M,. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study. Menopause. 2006;13(5):770–779
  • . Simon J, Braunstein G, Nachtigall L,. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab. 2005;90(9):5226–5233
  • . Seibel M. Men, women and testosterone: why did the FDA fail Intrinsa? Sex Reprod Menopause. 2005;1:1–2
  • . Sherwin BB, Gelfand MM. The role of androgen in the maintenance of sexual functioning in oophorectomized women. Psychosom Med. 1987;49(4):397–409
  • . Sherwin BB, Gelfand MM, Brender W. Androgen enhances sexual motivation in females: a prospective, crossover study of sex steroid administration in the surgical menopause. Psychosom Med. 1985;47(4): 339–351
  • . Rosen R, Brown C, Heiman J,. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26(2):191–208
  • . Novo Nordisk. http://press.novonordiskus.com/index.php?s=43&item=252. Accessed November 3, 2011

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.